Table 1. Characteristics of IE patient, France 2011.
Characteristics | n = 6,235 (%) |
---|---|
Male gender | 4,003 (64.2) |
Age, mean, (median, 25%, 75%) | 69 (72, 60, 81) |
Predisposing diseases | |
Chronic cardiac disease | 1,701 (27.3) |
Diabetes mellitus | 1,479 (23.7) |
Cancer | 1,004 (16.1) |
Chronic renal disease | 1,251 (20.1) |
Chronic respiratory disease | 894 (14,3) |
Intravenous drug use | 125 (2.0) |
Hemodialysis dependence | 345 (5.5) |
Valve status | |
Native valve | 4,488 (72.0) |
Valve prosthesis | 1,247 (20.0) |
Unknown | 500 (8.0) |
Pacemaker | 1,025(16.4) |
Microorganism | |
Monomicrobial | 3,490 (56.0) |
Streptococci/Enterococci | 1,557(44.6) |
Staphylococci | 1,531 (43.9) |
Gram-negative bacilli | 317 (9.1) |
Candida sp. | 46 (1.3) |
Coxiella burnetii | 17 (0.5) |
Bartonella henselae | 3 (0,1) |
Polymicrobial | 513 (8.2) |
Not documented | 2,232 (35.8) |
No microbiological code | 1,994(89.3) |
Code for non-specified pathogen | 238 (10.7) |
Complication | |
Cardiogenic shock | 511 (8.2) |
Stroke | 803 (12.9) |
Ischemic stroke | 586 (73.0) |
Hemorrhagic stroke | 217 (27.0) |
Acute ischemia of lower limb | 158 (2.5) |
Vertebral osteomyelitis | 292 (4.7) |
Valvular surgery | 1,576 (25.3) |
During initial stay | 635 (40.3) |
During one year follow-up | 941 (59.7) |
Death | 1,814 (29.1) |
During initial IE hospital stay | 1,283 (70.7) |
Death during follow-up | 531 (29.3) |